RIPE-KG · Version 1.1.0 · Resource
ripekg:work/10.3390%2Fmolecules26040856
https://w3id.org/ripe/ripe-kg/work/10.3390%2Fmolecules26040856
| Subject | Predicate | Object |
|---|---|---|
ripekg:work/10.3390%2Fmolecules26040856Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders |
prism:doi |
10.3390/molecules26040856 |
ripekg:work/10.3390%2Fmolecules26040856Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders |
dcterms:title |
Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders |
ripekg:work/10.3390%2Fmolecules26040856Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders |
rdf:type |
node1 |
ripekg:work/10.3390%2Fmolecules26040856Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.3390%2Fmolecules26040856Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders |
rdf:type |
rdfs:Resource |
ripekg:work/10.3390%2Fmolecules26040856Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders |
rdf:type |
owl:Thing |
ripekg:work/10.3390%2Fmolecules26040856Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders |
rdf:type |
prov:Entity |
ripekg:work/10.3390%2Fmolecules26040856Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders |
rdf:type |
ripe:WorkWork |
ripekg:work/10.3390%2Fmolecules26040856Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders |
owl:sameAs |
https://semopenalex.org/work/W3128445379 |
ripekg:work/10.3390%2Fv13060989RETRACTED: Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon |
http://purl.org/spar/cito/cites |
ripekg:work/10.3390%2Fmolecules26040856Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders |